Physicians' Academy for Cardiovascular Education

CDMC Asia

Intervening in the course of risk: Exploring new insights in diabetes & cardiovascular disease

Jan. 28, 2011

Intervening in the course of risk: Exploring new insights in diabetes & cardiovascular disease
 

Held in Shanghai, China in January, 2011

Scientific rationale
• To summarise the epidemiology and pathophysiology of patients at increased cardiovascular risk and diabetes
• To explore mechanisms and common pathways underlying the development of cardiovascular disease and diabetes
• To review and discuss the importance of glucose management and the rationale for early intervention strategies in patients with diabetes
• To discuss the role of anti-diabetic therapy, in particular the use of TZD’s, in a risk-based intervention strategy that targets glucose control and cardiovascular risk factors
• To provide an expert perspective on the expanding role of RAS blockade in multiple organs in the treatment of patients at increased CV risk
• To provide an expert perspective in the ongoing debate on the role of TZD’s in the treatment of patients with diabetes
• To discuss current and future strategies for practical management and interventions to prevent cardiovascular events in multirisk patients
 

The concept of Diabetes & CV risk:

A lifetime risk challenge

Prof John Deanfield, MD
University College London
London, United Kingdom
CDMC - Shanghai


 
 

TZD’s in the management of diabetes & CV disease:

All about benefits and safety

Prof. John Betteridge, MD
University College London
London, United Kingdom
CDMC - Shanghai 2011


 
 

(Pre) diabetes & sustained glycemic control:

How and what is the time to act?

Stanley S Schwartz, MD
University of Pennsylvania
Philadelphia, USA
CDMC - Shanghai 2011


 
 

RAS blockade in the real world:

Clinical lessons from recent trials

Sverre Kjeldsen, MD
Ullevaal University Hospital
Oslo, Norway
CDMC - Shanghai 2011


 
 

The expanding role of ARB’s in CV risk management

Does it matter how we block the system?

Peter Meredith, PhD
University of Glasgow
Glasgow, United Kingdom
CDMC - Sjanghai 2011

The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.

Share this page with your colleagues and friends: